Baseline characteristics
| Characteristic | All patients (n=72) |
|---|---|
| MS, multiple sclerosis; EDSS, Kurtzke expanded disability status scale16; ESS, Epworth sleepiness scale19; FSS, fatigue severity scale17. | |
| Mean age (y (range)) | 44 (23-61) |
| Female/male ratio | 3:1 |
| MS clinical course (% of patients): | |
| Relapsing-remitting | 74 |
| Primary progressive | 7 |
| Secondary progressive | 19 |
| Concomitant medications, (n (%) of patients): | |
| Interferon-β or glatiramer acetate | 55 (76) |
| Mean duration of MS (y (range)) | 6.3 (0-29) |
| Mean EDSS score (range) | 3.3 (0-6) |
| Mean FSS score (range) | 5.9 (4-7) |
| Mean ESS score (range) | 9.5 (1-20) |